J
OpenAI has acquired Orchestra Bio, a biotech startup.
OpenAI describes Orchestra Bio as “a platform that helps biopharma teams coordinate the complex process of drug development.” The company will bring Orchestra’s team and tech “together with Rosalind, our AI models and tools for life sciences research.”
OpenAI acquires Orchestra Bio
[OpenAI]
Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Loading comments
Getting the conversation ready...











